AL
Astellas Pharma Inc.
ALPMF · OTC
$15.45 -1.28% (-$0.20)
1M +14.87%
Market Cap ¥4.13T
P/E Ratio 11.31x
Div. Yield 3.44%
ROE 20.38%
Bulios Fair Price
$10.04
35.0% downside
Trenutna cena
$15.45
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ALPMF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
8/9Valuation
97 /100
Cheap P/E 11.31x
EV/EBITDA 6.34x
P/S 1.81x
Growth
32 /100
Declining EPS growth 25.04%
Rev. growth 13.84%
FCF growth 8.82%
Profitability
95 /100
Strong Gross margin 74.71%
Net margin 16.01%
Op. margin 21.78%
Quality
79 /100
Excellent ROIC 14.16%
ROE 20.38%
ROA 9.96%
Debt
93 /100
Low Debt/Equity 0.30x
Current ratio 1.20x
Int. coverage 44.80x
Stability
45 /100
Moderate Beta 0.09x
Rev. volatility 7.35%
EPS volatility 147.25%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ALPMF
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Naoki Okamura
Employees
14,099
Headquarters
Tokyo
Prihajajoči dogodki
29 SEP.
Ex-Dividend
Ex-dividend date
29 SEP.
Dividend Payment
Datum plačila
04 NOV.
Earnings
Upcoming earnings report
30 MAR.
Ex-Dividend
Ex-dividend date
30 MAR.
Dividend Payment
Datum plačila